Kate Hudson shared a snap of a sweet moment with her 7-year-old daughter Rani on Instagram. She also shared a few photos of her latest press tour look, a monochromatic brown leather outfit. Hudson ...
Huma Qureshi’s political saga 'Maharani Season 4' ends with one of the most dramatic cliffhangers of the series yet. Rani Bharti, once the Chief Minister of Bihar, sets her eyes on the ultimate prize ...
On November 6 th, Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) reported third quarter 2025 results. Since our last update following the announcement of the Chugai deal and the $60 million private ...
Kate Hudson's seven-year-old daughter Rani Rose got her ears pierced. The Running Point actress proudly filmed the milestone and later posted the video on TikTok. Hudson shares Rani with her longtime ...
Rani Therapeutics is initiated at a Buy rating, driven by major pipeline advancements and strong partnership momentum. RANI secured a $1.085 billion collaboration with Chugai Pharmaceutical, ...
With investors perched on the edge of their seats for months, Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) announces a deal including upfront milestones and partner-funded asset development. On ...
Financing led by Samsara BioCapital, L.P. (“Samsara”) with participation from additional investors, including RA Capital Management, Anomaly, Special Situations Funds, Invus and Mr. Mir Imran At the ...
Oct 17 (Reuters) - Rani Therapeutics (RANI.O), opens new tab on Friday announced a licensing deal to develop and sell an oral version of Chugai Pharmaceutical's (4519.T), opens new tab experimental ...
The company will receive an upfront payment of $10 million. It could also earn up to $75 million in development milestones, $100 million in sales milestones, and single-digit royalties on future ...
The collaboration aims to develop an oral product combining Rani’s RaniPill technology with Chugai’s rare disease antibody. Notably, Chugai has options to extend rights to up to five additional drug ...
Shares of Rani Therapeutics Holdings have doubled, to $1.12, in premarket trading after the company said it has entered into a collaboration and license agreement with Chugai Pharmaceutical. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback